EMEA Vaginal Panel Testing Market Set to Surpass US$175 Mn by 2031, Driven by Molecular Diagnostics, At-Home Testing
The Europe and Middle East & Africa (EMEA) vaginal panel testing market is entering a period of steady expansion as healthcare providers, diagnostic laboratories, and manufacturers increasingly adopt molecular testing technologies for the detection of common vaginal infections. Vaginal panel testing uses automated molecular diagnostic techniques, including real-time polymerase chain...
0 Comments 0 Shares 50 Views 0 Reviews